PRESS RELEASE published on 07/11/2024 at 07:30, 1 year 10 months ago ESPG gears Science Park portfolio towards sustainable power generation and achieves significant CO2 savings ESPG AG gears Science Park portfolio towards sustainable power generation, achieving significant CO2 savings. Installation of photovoltaic systems and future plans for more solar plants and energy efficiency measures Science Park ESPG AG Green Electricity CO2 Savings Sustainable Power Generation
PRESS RELEASE published on 07/11/2024 at 07:30, 1 year 10 months ago AGRANA: Challenging market environment weighs on results in financial first quarter AGRANA reports challenging market conditions impact financial results in the first quarter of 2024|25, with decreased revenue and EBIT. Details on business segments provided Financial Results Market Environment EBIT AGRANA Business Segments
PRESS RELEASE published on 07/11/2024 at 07:30, 1 year 10 months ago Eleventh acquisition in 2024: Mutares has successfully completed the acquisition of Wilda Transport och Entreprenad AB and NU Entreprenad AB from Wilton Invest AB Mutares SE & Co. KGaA completes the acquisition of Wilda Transport och Entreprenad AB and NU Entreprenad AB from Wilton Invest AB, strengthening Terranor AB with EUR 10 million revenues in 2023 Acquisition Revenues Mutares SE & Co. KGaA Wilda Transport Och Entreprenad AB Terranor AB
PRESS RELEASE published on 07/11/2024 at 07:30, 1 year 10 months ago Gerresheimer Remains on Track in 1st Half Year 2024 Gerresheimer reports 1.7% revenue growth and 2.9% adjusted EBITDA increase in 1st half 2024, with Plastics & Devices division showing dynamic growth and improved margin Revenue Growth Gerresheimer Adjusted EBITDA Increase Plastics & Devices Division Guidance Confirmed
PRESS RELEASE published on 07/11/2024 at 07:30, 1 year 10 months ago DRONE VOLT annonce le lancement d'une augmentation de capital ouverte à tous avec maintien du droit préférentiel de souscription DRONE VOLT lance une augmentation de capital avec maintien du droit préférentiel de souscription, visant jusqu'à 2,6 millions d'euros, pour financer sa croissance. Opportunité d'investissement stratégique Croissance Investissement Augmentation De Capital Droit Préférentiel De Souscription DRONE VOLT
PRESS RELEASE published on 07/11/2024 at 07:30, 1 year 10 months ago Inside Information / Other news releases GenSight Biologics launches a newsletter for retail investors providing updates, news articles, conferences, and financial figures in French, available via subscription on the company's website Subscription Retail Investors Newsletter French GenSight Biologics
PRESS RELEASE published on 07/11/2024 at 07:30, 1 year 10 months ago Informations privilégiées / Autres communiqués GenSight Biologics lance une lettre d'information destinée aux investisseurs particuliers en France, présentant des actualités et des informations sur la société et ses projets innovants Investisseurs Particuliers GenSight Biologics Thérapies Géniques Maladies Neurodégénératives Lettre D'information
PRESS RELEASE published on 07/11/2024 at 07:29, 1 year 10 months ago Fielmann Group grows HY1/2024 sales +12% over 2023, improves profitability Fielmann Group reports 12% sales growth in HY1/2024, with improved profitability and outlook for Vision 2025. Digitalization and international expansion drive growth Profitability Digitalization Fielmann Group HY1/2024 Sales Vision 2025
PRESS RELEASE published on 07/11/2024 at 07:15, 1 year 10 months ago Inside Information / Other news releases Eurofins provides update to key stakeholders on actions responding to Muddy Waters' reports and plans for related party transactions. Additionally, the company addresses cash accounting and corporate governance Corporate Governance Muddy Waters Related Party Transactions Stakeholders Eurofins
PRESS RELEASE published on 07/11/2024 at 07:05, 1 year 10 months ago Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business Heidelberg Pharma AG reports positive preliminary efficacy data for HDP-101 in multiple myeloma clinical trial. Key events include AACR Meeting presentation & FDA Orphan Drug Designation Clinical Trial HDP-101 Heidelberg Pharma AG AACR Meeting FDA Orphan Drug Designation
Published on 05/21/2026 at 01:25, 3 hours 40 minutes ago Mongolia Growth Group Announces Completion of Arrangement and Changes to the Board and Executive Leadership
Published on 05/20/2026 at 22:40, 6 hours 25 minutes ago Jaguar Health Reports First Quarter 2026 Financials
Published on 05/20/2026 at 22:15, 6 hours 50 minutes ago Fox River Resources Corporation Obtains Interim Order for Plan of Arrangement and Provides Details of Special Meeting
Published on 05/20/2026 at 15:28, 13 hours 37 minutes ago Sarama Resources Announces Private Equity Placement of A$1.5m
Published on 05/20/2026 at 15:01, 14 hours 4 minutes ago Kidoz Inc. Appoints Tarrnie Williams Jr. as Chief Operating Officer
Published on 05/20/2026 at 22:00, 7 hours 5 minutes ago Nebius and Bloom Energy partner to power AI infrastructure build-out
Published on 05/20/2026 at 21:35, 7 hours 29 minutes ago IGEL and Zscaler Release Healthcare Security Blueprints for Distributed Care Delivery
Published on 05/20/2026 at 20:15, 8 hours 49 minutes ago EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S expands capacity for AI substrates
Published on 05/20/2026 at 19:34, 9 hours 30 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Final Results Announcement
Published on 05/20/2026 at 19:34, 9 hours 31 minutes ago EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S intends to issue a (Hybrid) Convertible Bond and/or a Hybrid Bond; no dividend for the financial year 2025/26
Published on 05/20/2026 at 18:00, 11 hours 5 minutes ago General shareholders meeting of 20 May, 2026
Published on 05/20/2026 at 18:00, 11 hours 5 minutes ago General shareholders meeting of 20 May, 2026
Published on 05/20/2026 at 17:45, 11 hours 20 minutes ago Report on share repurchases from 13 to 19 May 2026